CNS Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is…

Biotechnology
US, Houston [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of CNSP's Analysis
CIK: 1729427 CUSIP: 18978H102 ISIN: US18978H2013 LEI: - UEI: -
Secondary Listings
CNSP has no secondary listings inside our databases.